Neuroone Medical Technologies Corp (OQ:NMTC)

Business Focus: Medical Diagnostic & Testing Equipment

Mar 26, 2024 09:00 am ET
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it...
Mar 08, 2024 12:00 pm ET
NeuroOne® to Participate in the 36th Annual Roth Conference
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced its...
Feb 23, 2024 05:10 pm ET
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announced that,...
Feb 13, 2024 04:00 pm ET
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces its...
Feb 08, 2024 03:30 pm ET
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference...
Dec 14, 2023 04:15 pm ET
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces its...
Dec 11, 2023 08:00 am ET
NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System
cleared device Potential for transformative improvement in neurosurgery procedures; Company targets commercial launch in first half of 2024 EDEN PRAIRIE, Minn., Dec. 11, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies...
Dec 07, 2023 04:30 pm ET
NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference...
Dec 05, 2023 08:31 am ET
Thinking about buying stock in Adial Pharmaceuticals, Ares Capital Corp, SilverSun Technologies, Neuroone Medical Technologies, or enGene Holdings?
NEW YORK, Dec. 5, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ADIL, ARCC, SSNT, NMTC, and ENGN.
Nov 16, 2023 08:00 am ET
NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today that,...
Nov 14, 2023 05:15 pm ET
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today that it...
Nov 07, 2023 08:00 am ET
NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today that it...
Oct 17, 2023 09:31 am ET
Thinking about buying stock in Faraday Future Intelligent Electric, Processa Pharmaceuticals, ZW Data Action Technologies, Neuroone Medical Technologies, or Vistagen Therapeutics?
NEW YORK, Oct. 17, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FFIE, PCSA, CNET, NMTC, and VTGN.
Oct 13, 2023 09:30 am ET
NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that...
Sep 06, 2023 04:00 pm ET
NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced its...
Aug 14, 2023 04:00 pm ET
NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces its...
Aug 08, 2023 04:00 pm ET
NeuroOne® to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference...
Jul 25, 2023 08:00 am ET
NeuroOne Medical Technologies Corporation Announces Pricing of Public Offering of Common Stock
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today the pricing of an...
Jul 24, 2023 04:03 pm ET
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today that it has commenced...
Jun 12, 2023 08:35 am ET
NeuroOne® Submits 510(k) Application to FDA for OneRF™ Ablation System 
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today its...
May 17, 2023 09:00 am ET
NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode in Robotic Neurosurgery
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced the...
May 11, 2023 04:00 pm ET
NeuroOne® Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces its...
May 11, 2023 12:17 pm ET
NeuroOne® to Report Second Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on May 11
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference...
May 10, 2023 09:00 am ET
NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode Performed at Mayo Clinic
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that...
May 05, 2023 03:08 pm ET
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announced that,...
May 05, 2023 09:00 am ET
NeuroOne® to Present at the Sidoti Micro-Cap Virtual Conference on May 10
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that...
May 02, 2023 09:00 am ET
NeuroOne® Announces U.S. Commercial Launch of Evo® sEEG Electrodes
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced the...
Apr 27, 2023 04:00 pm ET
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announced that,...
Apr 06, 2023 09:15 am ET
Minimally Invasive Surgery - This Company's Successful Trial Could Help Eliminate The Need For An Incision In Patients With Back Pain
EDEN PRAIRIE, MN / ACCESSWIRE / April 6, 2023 / As medical technology progresses, the world's approach to surgical operations is also advancing and changing significantly. As part of this, minimally invasive surgery (MIS), in recent years, has taken the forefront of the surgical industry, and there are no surprises why.
Mar 16, 2023 07:30 am ET
NeuroOne® Successfully Completes Initial Animal Implant of Novel Thin Film Paddle Lead for Spinal Cord Stimulation
Company is also developing a percutaneous (through a needle) delivery system for paddle leads
Mar 09, 2023 08:00 am ET
NeuroOne®#¹⁶⁰;to Participate in the 35th Annual Roth Conference
EDEN PRAIRIE, Minn., March 9, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced its participation in the 35th Annual Roth Conference being held March 12-14, 2023 in Dana Point, California. Dave Rosa, CEO of NeuroOne, will host one-on-one meetings with institutional investors and analysts on Monday, March 13th and Tuesday, March 14th.
Feb 09, 2023 08:00 am ET
NeuroOne® to Report First Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on February 14
EDEN PRAIRIE, Minn., Feb. 9, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call to discuss financial results for its fiscal first quarter 2023 ended December 31, 2022 and provide a corporate update on February 14, 2023 at 4:30 PM Eastern Time.
Jan 30, 2023 08:00 am ET
NeuroOne® Issues Letter to Shareholders
Company highlights fiscal year 2022 and subsequent achievements, catalysts for fiscal year 2023
Dec 22, 2022 08:00 am ET
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2022 Financial Results
EDEN PRAIRIE, Minn., Dec. 22, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC; "NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces financial results for the fiscal fourth quarter and full fiscal year ended September 30, 2022.
Dec 13, 2022 03:00 pm ET
NeuroOne® to Host Fiscal Fourth Quarter Corporate Update
EDEN PRAIRIE, Minn., Dec. 13, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC; "NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, to host fiscal Fourth Quarter Corporate Update for the period ended September 30, 2022.
Dec 08, 2022 08:00 am ET
NeuroOne® to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide Corporate Update on December 13
EDEN PRAIRIE, Minn., Dec. 8, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call to discuss financial results for its fiscal fourth quarter and full fiscal year ended September 30, 2022, and provide a corporate update, on December 13, 2022 at 4:30 PM Eastern Time.
Dec 06, 2022 08:00 am ET
NeuroOne® Successfully Completes Feasibility Study with its OneRF™ Ablation System
Animal study completed under the guidance of Dr. Jamie Van Gompel at the Mayo Clinic in Rochester, MN
Nov 30, 2022 08:00 am ET
NeuroOne® Ships Initial Zimmer Biomet Order for its Evo® sEEG System for Less than 30 Day Use
Company focused on manufacturing and commercialization in partnership with Zimmer Biomet
Nov 23, 2022 07:30 am ET
Thinking about buying stock in Carvana, Cosmos Holdings, Porch Group, NeuroOne Medical Technologies, or Manchester United?
NEW YORK, Nov. 23, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CVNA, COSM, PRCH, NMTC, and MANU.
Nov 22, 2022 08:00 am ET
NeuroOne® to Ring Nasdaq Stock Market Closing Bell on November 22
Ceremony to commemorate recent FDA clearance milestone for Company's Evo® sEEG Electrode technology
Nov 21, 2022 10:00 am ET
NeuroOne® CEO Dave Rosa Featured on Fox Business Network's 'Mornings with Maria'
EDEN PRAIRIE, Minn., Nov. 21, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces an appearance by Chief Executive Officer Dave Rosa on Fox Business Network's Mornings with Maria earlier today. The segment, which aired live at 8:45 a.m. ET, can be viewed online at on-air-mornings-with-maria.
Oct 25, 2022 09:00 am ET
NeuroOne® Receives FDA 510(k) Clearance to Market its Evo® sEEG System for Less than 30 Day Use
Company focused on manufacturing ramp for commercialization in partnership with Zimmer Biomet
Sep 22, 2022 09:00 am ET
NeuroOne Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn., Sept. 22, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announced that, effective September 20, 2022, the Compensation Committee of the Board of Directors approved two equity awards under the NeuroOne Medical Technologies Corporation 2021 Inducement Plan (the "Inducement Plan"), as a material inducement to the individuals entering into employment with the Company. The e
Aug 11, 2022 04:00 pm ET
NeuroOne® Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
EDEN PRAIRIE, Minn., Aug. 11, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces its operating results for the third quarter of fiscal year 2022 ended June 30, 2022.
Aug 09, 2022 09:00 am ET
NeuroOne® Submits Special 510(k) to FDA for Evo® sEEG Electrode
Company re-submits application to gain FDA clearance for less than 30 day use
Aug 04, 2022 09:00 am ET
NeuroOne® to Report Third Quarter Fiscal Year 2022 Financial Results on August 11
EDEN PRAIRIE, Minn., Aug. 4, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call to discuss financial results for its third quarter of fiscal 2022 ended June 30, 2022, on August 11, 2022 at 5:30 PM Eastern Time.
Aug 03, 2022 09:00 am ET
NeuroOne® Announces $3.5 Million Accelerated Milestone Payment from Zimmer Biomet for Evo® sEEG Electrode
Amendment provides Zimmer Biomet with 350,000 warrants with exercise price of $3.00 per share
Jul 12, 2022 09:00 am ET
NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode
Case performed at Emory University for intraoperative brain mapping
Jun 02, 2022 08:47 am ET
NeuroOne® Issues Letter to Stockholders in Connection With 2022 Annual Meeting of Stockholders
Letter recaps key highlights of fiscal year 2021 and features upcoming milestones for fiscal year 2022 and beyond
May 19, 2022 09:30 am ET
NeuroOne® to Present Its Breakthrough Technology for Monitoring Neural Activity at the H.C. Wainwright Global Investment Conference on May 25
EDEN PRAIRIE, Minn., May 19, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will present at the H.C. Wainwright Global Investment Conference being held May 23-26, 2022 virtually and in Miami, Florida. NeuroOne will present Wednesday, May 25, 2022, from 3:30 PM - 4:00 PM ET, and the presentation will be available on-demand via webcast.
May 16, 2022 04:30 pm ET
NeuroOne Provides Evo® sEEG Update
The Evo® sEEG electrode 510(k) cleared for temporary (less than 24 hours) use remains in effect and the Company will explore the opportunity to market the device for intraoperative use.
May 12, 2022 04:05 pm ET
NeuroOne Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
EDEN PRAIRIE, Minn., May 12, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces its operating results for the second quarter of fiscal year 2022 ended March 31, 2022.
May 03, 2022 09:00 am ET
NeuroOne® to Report Second Quarter Fiscal Year 2022 Financial Results on May 12
EDEN PRAIRIE, Minn., May 3, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call to discuss financial results for its second quarter of fiscal 2022, ended March 31, 2021, on May 12, 2022 at 4:30 PM Eastern Time.
Apr 18, 2022 10:00 am ET
NeuroOne® to Present its Disruptive Next-Generation Diagnostic Electrode Technology at the NobleCon18 Investor Conference on April 20, 2022
EDEN PRAIRIE, Minn., April 18, 2022  /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will present at NobleCon18, Noble Capital Markets' 18th Annual Investor Conference being held April 19-21, 2022.
Mar 30, 2022 10:00 am ET
NeuroOne® Investor Call Replay Available Through April 11th
EDEN PRAIRIE, Minn., March 30, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that a telephone replay of its investor conference call discussing recent disclosures, held yesterday, will be available through April 11, 2022. The webcast replay will be available for one year.
Mar 28, 2022 07:05 pm ET
NeuroOne® to Host Investor Call About Recent Disclosures Tomorrow March 29th at 10:00 am ET
EDEN PRAIRIE, Minn., March 28, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will host a conference call to discuss recent disclosures tomorrow, March 29, 2022, at 10:00 am Eastern Time. The purpose of the call is to provide clarification and answer questions regarding disclosure included in the Company's recent Current Report on Form 8-K filed on Friday, March 25, 2022 a
Mar 04, 2022 08:00 am ET
NeuroOne Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn., March 4, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announced that, effective March 1, 2022, the Compensation Committee of the Board of Directors approved an equity award under the NeuroOne Medical Technologies Corporation 2021 Inducement Plan (the "Inducement Plan"), as a material inducement to an individual entering into employment with the Company. The equity awar
Mar 03, 2022 08:00 am ET
NeuroOne to Present its Game-Changing Neuroscientific Technology at the Oppenheimer 32nd Annual Healthcare Conference and 34th Annual ROTH Conference
EDEN PRAIRIE, Minn., March 3, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it is scheduled to attend two investor conferences during the month of March 2022.
Mar 02, 2022 08:00 am ET
NeuroOne® Releases Successful Completion of Long-Term Stimulation Tests for its Novel Thin Film Platform Electrode Technology
EDEN PRAIRIE, Minn., March 2, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it successfully completed initial bench top, long-term stimulation testing on a novel design of its thin film electrode technology. The tests measured the electrodes' ability to deliver the number of electrical stimulation pulses required to meet approximately 5 years of use using an active accelerat
Feb 14, 2022 03:01 pm ET
NeuroOne Reports First Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
EDEN PRAIRIE, Minn., Feb. 14, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announces its operating results for the first quarter of fiscal year 2022 ended December 31, 2021.
Feb 08, 2022 08:00 am ET
NeuroOne® Medical Technologies Corporation Releases Successful Long-Term Recording Test Data for its Novel Thin Film Platform Electrode Technology
EDEN PRAIRIE, Minn., Feb. 8, 2022  /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it successfully completed initial pre-clinical long-term testing of recording capabilities on its platform thin film electrode technology. In test procedures, the electrodes' ability to record electrical activity over a span of 5 years was measured using an accelerated aging test model. The test resu
Feb 02, 2022 03:01 pm ET
NeuroOne to Host First Quarter Fiscal Year 2022 Earnings Call
EDEN PRAIRIE, Minn., Feb. 2, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today it will host a conference call to discuss financial results for its first quarter of fiscal 2022, ended December 31, 2021, on February 14, 2022 at 4:30 PM Eastern Time.
Jan 28, 2022 10:07 am ET
36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022
RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th - 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.
Jan 18, 2022 07:00 am ET
NeuroOne Appoints Chad Wilhelmy, as Vice President of Quality Control and Regulatory Affairs
EDEN PRAIRIE, Minn., Jan. 18, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announces the appointment of Chad Wilhelmy, as Vice President of Quality Control and Regulatory Affairs. Mr. Wilhelmy joins NeuroOne from HLT Medical, a subsidiary of the Bracco Group, where he was the Vice President Quality Assurance.
Dec 20, 2021 10:00 am ET
NeuroOne Featured on The Medical Alley Podcast: "A Conversation with Dave Rosa, President and CEO, NeuroOne"
EDEN PRAIRIE, Minn., Dec. 20, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, was featured on The Medical Alley Podcast, in an episode titled "A Conversation with Dave Rosa, President and CEO, NeuroOne."
Dec 15, 2021 07:00 am ET
NeuroOne Reports Fourth Fiscal Quarter and Full Fiscal Year 2021 Financial Results and Provides Corporate Update
EDEN PRAIRIE, Minn., Dec. 15, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC; "NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today financial results for the quarter and full fiscal year ended September 30, 2021.
Dec 06, 2021 12:55 pm ET
NeuroOne to Host Fourth Quarter 2021 Earnings Call
EDEN PRAIRIE, Minn., Dec. 6, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today it will host a conference call to discuss financial results for its fourth quarter and fiscal year ended September 30, 2021, on December 15, 2021, at 9:00 AM Eastern Time.
Oct 13, 2021 08:02 am ET
NeuroOne Medical Technologies Corporation Announces Pricing of Public Offering of Common Stock
EDEN PRAIRIE, Minn., Oct. 13, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced the pricing of an underwritten registered public offering of 3,750,000 shares of its common stock at a price of $3.20 per share.
Oct 12, 2021 07:03 pm ET
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
EDEN PRAIRIE, Minn., Oct. 12, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it has commenced a proposed underwritten registered public offering of shares of its common stock.
Sep 23, 2021 09:00 am ET
NeuroOne® Medical Technologies Corporation Announces Successful Completion of Feasibility Study for Ablation Electrode
EDEN PRAIRIE, Minn., Sept. 23, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it successfully completed an animal feasibility study of its combination recording and ablation technology at T3 Labs and Georgia State/Georgia Tech Center for Advanced Brain Imaging in Atlanta Georgia under the guidance of Dr. Robert Gross of Emory University. The study evaluated the ability of the Neu
Sep 09, 2021 09:00 am ET
NeuroOne to Present at H.C. Wainwright 23rd Annual Global Investment Conference
EDEN PRAIRIE, Minn., Sept. 9, 2021 /PRNewswire/ -- NeuroOne® Medical Technologies Corporation (Nasdaq: NMTC) (NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today that management will present at the H.C. Wainwright 23rd Annual Global Investment being held virtually from September 13th to 15th, 2021.
Sep 07, 2021 02:21 pm ET
NeuroOne® Medical Technologies Corporation Receives FDA 510(k) Clearance for its Evo® sEEG Electrode
EDEN PRAIRIE, Minn., Sept. 7, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its Evo sEEG Electrode technology for temporary (less than 24 hours) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of
Aug 25, 2021 11:00 am ET
NeuroOne Featured on Cheddar News (VIDEO): "Can This Brain Implant Save Lives?"
EDEN PRAIRIE, Minn., Aug. 25, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, was featured on Cheddar News, in a segment titled, "Can This Brain Implant Save Lives?" 
Aug 23, 2021 11:00 am ET
NeuroOne Announces Strategic Partnership with RBC Medical Innovations for Ablation Program
EDEN PRAIRIE, Minn., Aug. 23, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC; "NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today that it has executed an agreement with RBC Medical Innovations to develop and manufacture a proprietary radiofrequency (RF) generator for use with NeuroOne's combination recording and ablation electrode that is being designed to both record brain activity and ablate brain tissue using the same electrode. C
Aug 13, 2021 08:00 am ET
NeuroOne Reports Third Quarter Fiscal 2021 Financial Results and Corporate Update
EDEN PRAIRIE, Minn., Aug. 13, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC; "NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today financial results for the quarter ended June 30, 2021.
Aug 11, 2021 05:25 pm ET
NeuroOne to Host Third Quarter 2021 Earnings Call
EDEN PRAIRIE, Minn., Aug. 11, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today
Jul 28, 2021 09:00 am ET
NeuroOne to Participate in Alliance Global Partners (A.G.P.) Virtual MedTech Summer Conference on July 29, 2021
EDEN PRAIRIE, Minn., July 28, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today that the Company will participate in Alliance Global Partners (A.G.P.) Virtual MedTech Summer Conference on July 29, 2021.
Jul 08, 2021 11:20 am ET
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021
RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th - 15th, 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period as well as 1x1 meetings with qualified investors throughout the event.
Jul 07, 2021 09:00 am ET
NeuroOne to Present at Access to Giving Virtual Conference on July 15, 2021 at 2 p.m. ET
EDEN PRAIRIE, Minn., July 7, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC; NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today that the company will present at Access to Giving Virtual Conference.
Jun 23, 2021 09:35 am ET
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021
RALEIGH, NC / ACCESSWIRE / June 23, 2021 / Access to Giving - an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual presentations as well as private meetings with qualified investors throughout the three-day event.
Mar 18, 2021 09:00 am ET
NeuroOne Medical Technologies Corporation Presenting at the Benzinga Biotech Small Cap Conference
Detroit, Michigan--(Newsfile Corp. - March 18, 2021) - NeuroOne Medical Technologies Corporation (OTCQB:NMTC) will be presenting at the Benzinga Biotech Small Cap Conference taking place on March 24-25, 2021. We invite our shareholders and all interested parties to explore biotech small cap investment opportunities through two days of networking, deal-making and discovery.
Feb 23, 2021 07:00 am ET
NeuroOne Medical Technologies Corporation Announces Successful Completion of First Performance Milestone in Zimmer Biomet Agreement
EDEN PRAIRIE, Minn., Feb. 23, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today that it has successfully met the first performance milestone in the distribution and development agreement that was signed with Zimmer Biomet on July 20, 2020. In addition to acquiring the exclusive global distribution rights to NeuroOne's Evo™ (Evo) patented electrode technology, the partnership also offered t
Jan 15, 2021 07:00 am ET
NeuroOne Medical Technologies Corporation Closes $12.5 Million Private Placement with Certain Prominent Institutional Investors, Advances Towards Nasdaq Uplisting
EDEN PRAIRIE, Minn., Jan. 15, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today the closing of a previously announced private placement for the sale of 12,500,000 shares of its common stock and corresponding warrants to purchase 12,500,000 shares of its common stock. Each share of common stock and corresponding warrant is being sold at an aggregate purchase price of $1.00 for gross proceed
Jan 12, 2021 03:30 pm ET
NeuroOne Medical Technologies Corporation Announces Private Placement
EDEN PRAIRIE, Minn., Jan. 12, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today that it has entered into a definitive purchase agreement for the sale of 12,500,000 shares of its common stock and corresponding warrants to purchase 12,500,000 shares of its common stock to certain investors in a private placement.  Each share of common stock and corresponding warrant is being sold at an aggregate purchase p
Jan 07, 2021 07:00 am ET
NeuroOne Medical Technologies Corporation Appoints Ronald McClurg, Experienced Financial Industry Executive, as Chief Financial Officer
EDEN PRAIRIE, Minn., Jan. 7, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today the appointment of Ronald McClurg, an experienced senior financial industry executive, as Chief Financial Officer of NeuroOne Medical Technologies Corporation. Mr. McClurg has over 30 years of financial leadership experience with both public and privately held companies. He has held the role of CFO for a number of public compa
Dec 03, 2020 07:00 am ET
NeuroOne® Medical Technologies Corporation Announces First Human Commercial Use of its Evo™ Cortical Electrode at Mayo Clinic
EDEN PRAIRIE, Minn., Dec. 3, 2020 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today the first human commercial use of its Evo Cortical Electrode at Mayo Clinic in Rochester, Minnesota.
Sep 30, 2020 08:00 am ET
NeuroOne Medical Technologies Corporation Releases White Paper: Thin-Film Electrodes Show Potential for Transforming Neurosurgery
NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care options and outcomes for patients suffering from brain and spine-related neurological disorders, today announces the release of its white paper, “
Jul 28, 2020 08:00 am ET
NeuroOne Medical Technologies Corporation Reduces Debt by $3.3 Million and Strengthens Balance Sheet
NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces that during July 2020, the Company retired approximately $3.3 million of debt, strengthening the Compa
Jul 22, 2020 08:00 am ET
NeuroOne Medical Technologies Corporation Enters into Exclusive Development and Distribution Agreement for Commercialization of Diagnostic Evo Cortical Electrode
NeuroOne Medical Technologies Corporation (OTCQB: NMTC), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces the execution of an Exclusive Development and Distribution Agreement with
Jun 16, 2020 09:00 am ET
NeuroOne Medical Technologies Corporation Appoints Dr. Camilo Andres Diaz-Botia, Former Lead of Process Engineering at Neuralink, as Director of Electrode Development
NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces the appointment of Dr. Camilo Andres Diaz-Botia, a highly experienced neural engineer whose work has f
Apr 28, 2020 08:00 am ET
NeuroOne Medical Technologies Corp. Appoints Vanessa Tolosa to Scientific Advisory Board: Leading Researcher in Neurotech to Guide Further Development of Thin-film Electrodes
NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today the appointment of Vanessa Tolosa to its Scientific Advisory Board. Tolosa, one of the founding members of Ne
Feb 24, 2020 08:30 am ET
NeuroOne Medical Technologies Corporation Appoints Edward Andrle as New Board Member
EDEN PRAIRIE, MN / ACCESSWIRE / February 24, 2020 / NeuroOne Medical Technologies Corporation (OTCQB:NMTC), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today the appointment of Edward Andrle to the Company's Board of Directors.
Jan 21, 2020 07:00 am ET
Emerging Markets Report - NeuroOne Medical Technologies Receives FDA 510(k) Clearance
For investors seeking outsized growth, Life Sciences--the more speculative end of the healthcare sector--is certainly one sub-industry that’s hard to beat. Granted, investments in this space might carry a greater degree of risk, but that can be...
Dec 12, 2019 07:00 am ET
Emerging Markets Report: First and Foremost
In a previous editorial regarding NeuroOne Medical Technologies Corporation (OTCQB:NMTC), we opined as to how important it was that the Company recorded its first product sale to one of the top 5 hospitals in US News 2019-2020 annual rankings of...
Dec 02, 2019 09:00 am ET
NeuroOne Medical Technologies Corporation Receives FDA 510(k) Clearance for Evo(TM) Cortical Electrode
The Company believes that the Evo Cortical Electrode is the first cortical electrode to receive FDA 510(k) clearance that uses thin film printed microcircuit technology manufactured using a fully automated photolithographic process
Nov 25, 2019 07:00 am ET
Emerging Markets Report: Follow the Leader
The Life Science industry is perhaps one of the most exciting industries represented in the stock market. Not only are the market sectors often massive and rife with revenue potential, the products and services in Life Science deals can truly be...
Oct 01, 2019 09:00 am ET
NeuroOne Medical Technologies Corporation Provides Update on 510(k) Submission to the FDA
Company resubmits 510(k) regarding cortical electrode technology directly to the FDA for review
Sep 23, 2019 06:00 am ET
NeuroOne(TM) Medical Technologies Corporation Announces First Sale of sEEG Depth Electrode
Company's sEEG Electrode will be used for non-human research purposes by the Cleveland Clinic Foundation
Apr 15, 2019 06:00 am ET
NeuroOne Medical Technologies Corporation Appoints Chief Technology Officer
MINNETONKA, MN / ACCESSWIRE / April 15, 2019 / NeuroOne Medical Technologies Corporation (OTCQB: NMTC), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced the hiring of Steve Mertens as Chief Technology Officer.
Jan 30, 2019 06:00 am ET
NeuroOne Medical Technologies Announces Hiring Of Senior Staff
NeuroOne Medical Technologies Corporation (OTCQB: NMTC), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced the hiring of Leah Noaeill as Senior...
Nov 13, 2018 06:00 am ET
NeuroOne Medical Technologies Corporation Announces Appointments to Artificial Intelligence Advisory Board
NeuroOne Medical Technologies Corporation (OTCQB: NMTC), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, introduced five members that have been appointed to...
Sep 27, 2018 08:00 am ET
NeuroOne Medical Technologies Corporation Appoints Neuroscience Expert Kip Ludwig, PhD To Chair Artificial Intelligence Advisory Board
NeuroOne Medical Technologies Corporation (OTCQB: NMTC), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today the creation of a new Artificial...
Aug 24, 2018 04:58 pm ET
NeuroOne Medical Technologies Corporation Issues Statement Regarding Recent Promotional Activity Involving Its Common Stock
NeuroOne Medical Technologies Corporation (OTCQB:NMTC), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy, announced that it has...
May 23, 2018 06:00 am ET
NeuroOne Medical Technologies Announces 2017 Achievements and Provides Corporate Update
NeuroOne Medical Technologies Corporation (OTCQB:NMTC) today reported business highlights for the fiscal year ended December 31, 2017 and outlined plans for 2018. Dave Rosa, CEO of NeuroOne stated, “In 2017, we made great progress in our efforts...
May 17, 2018 07:00 am ET
NeuroOne Medical Technologies Corporation Announces Appointment to Scientific Advisory Board
NeuroOne Medical Technologies Corporation (NMTC), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced the appointment of Dr. Joseph Madsen to the...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.